Advanced
  Home Compare Reports

Comparison with Similar Reports

Ablation Technology Market by Product (Radiofrequency, Laser, Ultrasound (ESWL,HIFU), Microwave, Electrical), Application (Cardiovascular, Cancer, Gyn...

Publisher:       

# of Pages:        222

Rating: 

1 User License $4,950

Publication Date:  August, 2021

Price:       $4,950 / User License




1 INTRODUCTION 30
1.1 OBJECTIVES OF THE STUDY 30
1.2 MARKET DEFINITION 30
1.2.1 INCLUSIONS & EXCLUSIONS 30
1.3 MARKET SCOPE 31
1.3.1 MARKETS COVERED 31
1.3.2 GEOGRAPHIC SCOPE 32
1.3.3 YEARS CONSIDERED FOR THE STUDY 32
1.4 CURRENCY 33
TABLE 1 STANDARD CURRENCY CONVERSION RATES 33
1.5 LIMITATIONS 33
1.6 STAKEHOLDERS 33
1.7 SUMMARY OF CHANGES 34
2 RESEARCH METHODOLOGY 35
2.1 RESEARCH DATA 35
FIGURE 1 ABLATION TECHNOLOGY MARKET: RESEARCH DESIGN METHODOLOGY 35
2.1.1 SECONDARY RESEARCH 36
2.1.1.1 Key data from secondary sources 36
2.1.2 PRIMARY RESEARCH 38
FIGURE 2 PRIMARY SOURCES 38
2.1.2.1 Key data from primary sources 39
FIGURE 3 BREAKDOWN OF SUPPLY-SIDE PRIMARY INTERVIEWS:
BY COMPANY TYPE, DESIGNATION, AND REGION 40
FIGURE 4 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 40
2.2 MARKET SIZE ESTIMATION 41
2.2.1 TOTAL MARKET SIZE: ABLATION TECHNOLOGY MARKET 41
2.2.1.1 Bottom-up approach 41
FIGURE 5 MARKET SIZE ESTIMATION: ABLATION TECHNOLOGY MARKET
(BOTTOM-UP APPROACH) 42
2.2.1.2 Growth forecast 42
FIGURE 6 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 43
2.2.2 MARKET SEGMENT ASSESSMENT (BY PRODUCT, APPLICATION,
AND END USER) 43
FIGURE 7 TOP-DOWN APPROACH 43
2.2.3 GEOGRAPHIC MARKET ASSESSMENT (BY REGION & COUNTRY) 44
2.2.4 PRIMARY RESEARCH VALIDATION 44
2.3 COVID-19 HEALTH ASSESSMENT 44
2.4 COVID-19 ECONOMIC ASSESSMENT 45
 
2.5 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO 45
FIGURE 8 CRITERIA IMPACTING THE GLOBAL ECONOMY 45
FIGURE 9 RECOVERY SCENARIO OF THE GLOBAL ECONOMY 46
2.6 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO IN THE ABLATION TECHNOLOGY MARKET 47
2.7 MARKET BREAKDOWN AND DATA TRIANGULATION 48
FIGURE 10 ABLATION TECHNOLOGY MARKET: DATA TRIANGULATION METHODOLOGY 48
2.8 RESEARCH ASSUMPTIONS AND LIMITATIONS 49
2.8.1 ASSUMPTIONS FOR THE STUDY 49
2.9 RISK ASSESSMENT 49
TABLE 2 RISK ASSESSMENT: ABLATION TECHNOLOGY MARKET 49
3 EXECUTIVE SUMMARY 50
FIGURE 11 ABLATION TECHNOLOGY MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION) 50
FIGURE 12 ABLATION TECHNOLOGY MARKET, BY APPLICATION,
2021 VS. 2026 (USD MILLION) 51
FIGURE 13 ABLATION TECHNOLOGY MARKET, BY END USER,
2021 VS. 2026 (USD MILLION) 51
FIGURE 14 ABLATION TECHNOLOGY MARKET, BY REGION,
2021 VS. 2026 (USD MILLION) 52
4 PREMIUM INSIGHTS 53
4.1 ABLATION TECHNOLOGY MARKET OVERVIEW 53
FIGURE 15 EXPANSION OF THE TARGET POPULATION TO DRIVE MARKET GROWTH 53
4.2 ABLATION TECHNOLOGY MARKET, BY PRODUCT 54
FIGURE 16 RADIOFREQUENCY ABLATORS WILL CONTINUE TO DOMINATE
THE ABLATION TECHNOLOGY MARKET BY 2026 54
4.3 ABLATION TECHNOLOGY MARKET, BY END USER 54
FIGURE 17 HOSPITALS, SURGICAL CENTERS, AND ABLATION CENTERS ARE
THE LARGEST END USERS OF ABLATION TECHNOLOGY 54
5 MARKET OVERVIEW 55
5.1 INTRODUCTION 55
5.2 MARKET DYNAMICS 55
FIGURE 18 MARKET DYNAMICS: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 55
5.2.1 DRIVERS 55
5.2.1.1 Increasing demand for minimally invasive/non-invasive procedures 55
5.2.1.2 The emergence of next-generation ablation products & technologies 56
5.2.1.3 Expansion of the target patient population 57
5.2.1.3.1 Rapid growth in the aging population with a higher risk of targeted diseases 57
TABLE 3 GERIATRIC POPULATION, BY REGION, 2015 VS 2030 57
5.2.1.3.2 Growing incidence of sports injuries and cancer 58
5.2.1.3.3 Growing prevalence of atrial fibrillation and other cardiac conditions 59
5.2.1.4 The increasing number of hospitals and surgical & ablation centers 59
5.2.2 RESTRAINTS 60
5.2.2.1 Insufficient evidence and unfavorable regulatory scenario 60
5.2.2.2 Strong market positioning of alternative therapies 60
TABLE 5 ALTERNATIVE THERAPIES/PROCEDURES TO ABLATION 61
5.2.3 OPPORTUNITIES 61
5.2.3.1 Growth potential in emerging economies 61
5.2.4 CHALLENGES 62
5.2.4.1 Product recalls 62
5.2.4.2 Reuse and reprocessing of devices 62
5.2.4.3 Therapeutic challenges and hazardous effects of ablation 63
5.3 REGULATORY LANDSCAPE 64
TABLE 6 INDICATIVE LIST OF REGULATORY AUTHORITIES GOVERNING ABLATION DEVICES 64
5.3.1 NORTH AMERICA 65
5.3.1.1 US 65
TABLE 7 US FDA: MEDICAL DEVICE CLASSIFICATION 65
TABLE 8 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 65
FIGURE 19 PREMARKET NOTIFICATION: 510(K) APPROVALS FOR MEDICAL DEVICES 66
5.3.1.2 Canada 66
FIGURE 20 CANADA: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES 67
5.3.2 EUROPE 68
FIGURE 21 EUROPE: CE APPROVAL PROCESS FOR MEDICAL DEVICES 69
5.3.3 ASIA PACIFIC 70
5.3.3.1 Japan 70
TABLE 10 JAPAN: PMDA CLASSIFICATION OF ABLATION DEVICES 70
TABLE 11 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PHARMACEUTICAL AND MEDICAL DEVICE AGENCY (PMDA) 70
5.3.3.2 China 71
TABLE 12 CHINA: CLASSIFICATION OF MEDICAL DEVICES 71
5.3.3.3 India 72
TABLE 13 INDIA: CDSCO CLASSIFICATION OF ABLATION DEVICES 73
5.4 VALUE CHAIN ANALYSIS 73
FIGURE 22 VALUE CHAIN ANALYSIS OF THE ABLATION TECHNOLOGY MARKET 73
5.5 SUPPLY CHAIN ANALYSIS 74
TABLE 14 SUPPLY CHAIN ECOSYSTEM 74
5.6 ECOSYSTEM COVERAGE: PARENT MARKET 75
5.7 REIMBURSEMENT SCENARIO 75
TABLE 15 MEDICAL REIMBURSEMENT CPT CODES FOR MICROWAVE AND RADIOFREQUENCY ABLATION PROCEDURES IN
THE US (EFFECTIVE JANUARY 1, 2021) 76
5.8 PRICING TREND ANALYSIS 77
5.9 TRADE ANALYSIS 78
5.9.1 TRADE ANALYSIS FOR INSTRUMENTS AND APPLIANCES USED IN MEDICAL, SURGICAL, OR VETERINARY SCIENCES 78
TABLE 16 IMPORT DATA FOR INSTRUMENTS AND APPLIANCES USED IN MEDICAL, SURGICAL, OR VETERINARY SCIENCES, BY COUNTRY,
2016–2020 (USD BILLION) 78
5.10 PORTER’S FIVE FORCE ANALYSIS 78
TABLE 17 ABLATION TECHNOLOGY MARKET: PORTER’S FIVE FORCES ANALYSIS 78
5.10.1 THREAT FROM NEW ENTRANTS 79
5.10.2 THREAT OF SUBSTITUTES 79
5.10.3 BARGAINING POWER OF SUPPLIERS 80
5.10.4 BARGAINING POWER OF BUYERS 80
5.10.5 INTENSITY OF COMPETITIVE RIVALRY 80
5.11 COVID-19 IMPACT ON THE ABLATION TECHNOLOGY MARKET 81
6 ABLATION TECHNOLOGY MARKET, BY TYPE 83
6.1 INTRODUCTION 84
TABLE 18 ABLATION TECHNOLOGY MARKET, BY TYPE, 2019–2026 (USD MILLION) 84
6.2 RADIOFREQUENCY ABLATION 84
6.2.1 THE LOW COST OF RADIOFREQUENCY ABLATION CONTRIBUTES TO MARKET GROWTH 84
TABLE 19 RADIOFREQUENCY ABLATION TECHNOLOGY MARKET,
BY REGION, 2019–2026 (USD MILLION) 85
6.3 LASER/LIGHT ABLATION 86
6.3.1 HIGH EFFICACY AND SAFETY DRIVE THE ADOPTION OF LASER/LIGHT ABLATION 86
TABLE 20 LASER/LIGHT ABLATION TECHNOLOGY MARKET, BY REGION,
2019–2026 (USD MILLION) 86
6.4 ULTRASOUND ABLATION 86
6.4.1 TECHNOLOGICAL ADVANCEMENTS IN THE ULTRASOUND ABLATION SEGMENT WILL BOOST MARKET GROWTH 86
TABLE 21 ULTRASOUND ABLATION TECHNOLOGY MARKET, BY REGION,
2019–2026 (USD MILLION) 87
6.5 ELECTRICAL ABLATION 87
6.5.1 THE USE OF ELECTRICAL ABLATION TECHNOLOGY IN CARDIOVASCULAR AND CANCER CONDITIONS WILL BOOST MARKET GROWTH 87
TABLE 22 ELECTRICAL ABLATION TECHNOLOGY MARKET, BY REGION,
2019–2026 (USD MILLION) 88
6.6 CRYOABLATION 88
6.6.1 INCREASING FOCUS ON COSMETIC SURGERY IS A KEY MARKET GROWTH DRIVER 88
TABLE 23 CRYOABLATION TECHNOLOGY MARKET, BY REGION,
2019–2026 (USD MILLION) 89
 
6.7 MICROWAVE ABLATION 89
6.7.1 ADVANTAGES OVER RF ABLATION WILL ENSURE DEMAND FOR MICROWAVE ABLATION 89
TABLE 24 MICROWAVE ABLATION TECHNOLOGY MARKET, BY REGION,
2019–2026 (USD MILLION) 90
6.8 HYDROTHERMAL/HYDROMECHANICAL ABLATION 90
6.8.1 INCREASING USAGE IN GYNECOLOGY WILL HELP IN MARKET GROWTH 90
TABLE 25 HYDROTHERMAL/HYDROMECHANICAL ABLATION TECHNOLOGY MARKET,
BY REGION, 2019–2026 (USD MILLION) 91
7 ABLATION TECHNOLOGY MARKET, BY PRODUCT 92
7.1 INTRODUCTION 93
TABLE 26 ABLATION TECHNOLOGY MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 93
7.2 RADIOFREQUENCY ABLATORS 93
TABLE 27 RADIOFREQUENCY ABLATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 94
TABLE 28 RADIOFREQUENCY ABLATORS MARKET, BY REGION,
2019–2026 (USD MILLION) 94
7.2.1 TEMPERATURE-CONTROLLED RADIOFREQUENCY ABLATORS 94
7.2.1.1 Clinical advantages of temperature-controlled RF ablators over traditional approaches are driving the market 94
TABLE 29 TEMPERATURE-CONTROLLED RADIOFREQUENCY ABLATORS MARKET,
BY REGION, 2019–2026 (USD MILLION) 95
7.2.2 FLUID-COOLED RADIOFREQUENCY ABLATORS 95
7.2.2.1 Better temperature control as compared to other traditional radiofrequency ablators 95
TABLE 30 FLUID-COOLED RADIOFREQUENCY ABLATORS MARKET, BY REGION,
2019–2026 (USD MILLION) 96
7.2.3 ROBOTIC CATHETER MANIPULATION SYSTEMS 96
7.2.3.1 The effectiveness of remote catheter manipulators in AF will propel market growth 96
TABLE 31 ROBOTIC CATHETER MANIPULATION SYSTEMS MARKET, BY REGION,
2019–2026 (USD MILLION) 96
7.3 LASER/LIGHT ABLATORS 97
TABLE 32 LASER/LIGHT ABLATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 97
TABLE 33 LASER/LIGHT ABLATORS MARKET, BY REGION, 2019–2026 (USD MILLION) 97
7.3.1 EXCIMER LASER ABLATORS 98
7.3.1.1 Increasing use of excimer laser ablators in ophthalmological applications is a key driver of the market 98
TABLE 34 EXCIMER LASER ABLATORS MARKET, BY REGION,
2019–2026 (USD MILLION) 98
7.3.2 COLD LASER ABLATORS 98
7.3.2.1 Cold laser ablator treatment releases endorphins to support pain management 98
TABLE 35 COLD LASER ABLATORS MARKET, BY REGION, 2019–2026 (USD MILLION) 99
7.4 ULTRASOUND ABLATORS 99
TABLE 36 ULTRASOUND ABLATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 99
TABLE 37 ULTRASOUND ABLATORS MARKET, BY REGION, 2019–2026 (USD MILLION) 100
7.4.1 ULTRASONIC SURGICAL ABLATION SYSTEMS 100
7.4.1.1 Ultrasonic surgical ablators dominate the ultrasound ablators market 100
TABLE 38 ULTRASONIC SURGICAL ABLATION SYSTEMS MARKET, BY REGION,
2019–2026 (USD MILLION) 100
7.4.2 HIGH-INTENSITY FOCUSED ULTRASOUND ABLATORS 101
7.4.2.1 Low procedural times and reduced bleeding support product adoption 101
TABLE 39 HIGH-INTENSITY FOCUSED ULTRASOUND ABLATORS MARKET, BY REGION, 2019–2026 (USD MILLION) 101
7.4.3 EXTRACORPOREAL SHOCKWAVE LITHOTRIPSY SYSTEMS 101
7.4.3.1 Growing incidence of obesity and diabetes drive the market growth 101
TABLE 40 EXTRACORPOREAL SHOCKWAVE LITHOTRIPSY SYSTEMS MARKET,
BY REGION, 2019–2026 (USD MILLION) 102
7.4.4 MAGNETIC RESONANCE-GUIDED FOCUSED ULTRASOUND ABLATORS 102
7.4.4.1 A combination of techniques allows for high efficacy 102
TABLE 41 MAGNETIC RESONANCE-GUIDED FOCUSED ULTRASOUND ABLATORS MARKET, BY REGION, 2019–2026 (USD MILLION) 103
7.5 ELECTRICAL ABLATORS 103
TABLE 42 ELECTRICAL ABLATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 103
TABLE 43 ELECTRICAL ABLATORS MARKET, BY REGION, 2019–2026 (USD MILLION) 104
7.5.1 ARGON PLASMA/BEAM COAGULATORS 104
7.5.1.1 Increasing preference for APC is a key driver of the market 104
TABLE 44 ARGON PLASMA/BEAM COAGULATORS MARKET, BY REGION,
2019–2026 (USD MILLION) 105
7.5.2 IRREVERSIBLE ELECTROPORATION ABLATORS 105
7.5.2.1 IRE provides selective targeting and better control 105
TABLE 45 IRREVERSIBLE ELECTROPORATION ABLATORS MARKET, BY REGION,
2019–2026 (USD MILLION) 105
7.6 CRYOABLATION DEVICES 106
TABLE 46 CRYOABLATION DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 106
TABLE 47 CRYOABLATION DEVICES MARKET, BY REGION, 2019–2026 (USD MILLION) 106
7.6.1 TISSUE CONTACT PROBES 106
7.6.1.1 The safety and effectiveness of tissue contact probes have driven their use 106
TABLE 48 TISSUE CONTACT PROBES MARKET, BY REGION, 2019–2026 (USD MILLION) 107
7.6.2 TISSUE SPRAY PROBES 107
7.6.2.1 The ability to treat surgically inoperable tumors is driving the use of spray probes 107
TABLE 49 TISSUE SPRAY PROBES MARKET, BY REGION, 2019–2026 (USD MILLION) 107
7.6.3 EPIDERMAL & SUBCUTANEOUS CRYOABLATION DEVICES 108
7.6.3.1 Anesthetic properties of epidermal & subcutaneous probes are supporting market growth 108
TABLE 50 EPIDERMAL & SUBCUTANEOUS CRYOABLATION DEVICES MARKET,
BY REGION, 2019–2026 (USD MILLION) 108
7.7 MICROWAVE ABLATORS 108
TABLE 51 MICROWAVE ABLATORS MARKET, BY REGION, 2019–2026 (USD MILLION) 109
7.7.1 MICROWAVE THERMOTHERAPY DEVICES 109
7.8 HYDROTHERMAL/HYDROMECHANICAL ABLATORS 110
TABLE 52 HYDROTHERMAL/HYDROMECHANICAL ABLATORS MARKET, BY REGION, 2019–2026 (USD MILLION) 110
7.8.1 ENDOMETRIAL HYDROTHERMAL BALLOON ABLATION DEVICES 110
8 ABLATION TECHNOLOGY MARKET, BY APPLICATION 111
8.1 INTRODUCTION 112
TABLE 53 ABLATION TECHNOLOGY MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 112
8.2 CARDIOVASCULAR DISEASE TREATMENT 112
8.2.1 THE GROWTH OF THE TARGET PATIENT POPULATION WILL CONTINUE TO PROPEL THE DEMAND FOR CARDIAC ABLATION DEVICES 112
TABLE 54 ABLATION TECHNOLOGY MARKET FOR CARDIOVASCULAR DISEASE TREATMENT, BY REGION, 2019–2026 (USD MILLION) 113
8.3 CANCER TREATMENT 113
8.3.1 RISING PREVALENCE OF CANCER TO PROPEL MARKET GROWTH 113
TABLE 55 COUNTRY-WISE CANCER INCIDENCE PER MILLION POPULATION,
2015–2019 114
8.3.2 LIVER CANCER 114
8.3.3 KIDNEY CANCER 114
8.3.4 PROSTATE CANCER 114
8.3.5 LUNG CANCER 115
8.3.6 BONE METASTASIS 115
8.3.7 BREAST CANCER 115
TABLE 56 ABLATION TECHNOLOGY MARKET FOR CANCER TREATMENT, BY REGION, 2019–2026 (USD MILLION) 115
8.4 ORTHOPEDIC TREATMENT 115
8.4.1 GROWING DISEASE PREVALENCE AND RISING GERIATRIC POPULATION DRIVE DEMAND FOR ABLATION IN ORTHOPEDIC TREATMENT 115
TABLE 57 ABLATION TECHNOLOGY MARKET FOR ORTHOPEDIC TREATMENT, BY REGION, 2019–2026 (USD MILLION) 116
8.5 COSMETIC/AESTHETIC SURGERY 116
8.5.1 COSMETIC/AESTHETIC SURGERY TO SEE HIGH GROWTH IN THE COMING YEARS 116
TABLE 58 ABLATION TECHNOLOGY MARKET FOR COSMETIC/AESTHETIC SURGERY,
BY REGION, 2019–2026 (USD MILLION) 117
8.6 UROLOGICAL TREATMENT 117
8.6.1 THE HIGH PREVALENCE OF KIDNEY STONES IS A PROMINENT DRIVER OF MARKET GROWTH 117
TABLE 59 ABLATION TECHNOLOGY MARKET FOR UROLOGICAL TREATMENT, BY REGION, 2019–2026 (USD MILLION) 118
 
8.7 GYNECOLOGICAL TREATMENT 118
8.7.1 INCREASING PREVALENCE OF GYNECOLOGICAL CONDITIONS AND REPRODUCTIVE HEALTH CONCERNS TO BOOST MARKET GROWTH 118
TABLE 60 ABLATION TECHNOLOGY MARKET FOR GYNECOLOGICAL TREATMENT,
BY REGION, 2019–2026 (USD MILLION) 119
8.8 PAIN MANAGEMENT 119
8.8.1 RISING DEMAND OF MIS TO HELP SUSTAIN MARKET GROWTH 119
TABLE 61 ABLATION TECHNOLOGY MARKET FOR PAIN MANAGEMENT,
BY REGION, 2019–2026 (USD MILLION) 120
8.9 OPHTHALMOLOGICAL TREATMENT 120
8.9.1 THE RISING PREVALENCE OF VISION DISORDERS AND GROWING POPULATION WILL DRIVE THE MARKET GROWTH 120
TABLE 62 ABLATION TECHNOLOGY MARKET FOR OPHTHALMOLOGICAL TREATMENT,
BY REGION, 2019–2026 (USD MILLION) 121
8.10 OTHER APPLICATIONS 121
TABLE 63 ABLATION TECHNOLOGY MARKET FOR OTHER APPLICATIONS, BY REGION, 2019–2026 (USD MILLION) 121
9 ABLATION TECHNOLOGY MARKET, BY END USER 122
9.1 INTRODUCTION 123
TABLE 64 ABLATION TECHNOLOGY MARKET, BY END USER, 2019–2026 (USD MILLION) 123
9.2 HOSPITALS, SURGICAL CENTERS, AND ABLATION CENTERS 123
9.2.1 HOSPITALS, SURGICAL CENTERS, AND ABLATION CENTERS ARE THE MAJOR END USERS OF THE MARKET 123
TABLE 65 ABLATION TECHNOLOGY MARKET FOR HOSPITALS, SURGICAL CENTERS, AND ABLATION CENTERS, BY REGION, 2019–2026 (USD MILLION) 124
9.3 AMBULATORY SURGICAL CENTERS 124
9.3.1 PATIENTS ARE INCREASINGLY OPTING FOR AMBULATORY CARE AS A MORE CONVENIENT ALTERNATIVE TO HOSPITAL-BASED OUTPATIENT PROCEDURES 124
TABLE 66 NUMBER OF MEDICARE-CERTIFIED ASCS IN THE US (2013–2018) 125
TABLE 67 ABLATION TECHNOLOGY MARKET FOR AMBULATORY SURGICAL CENTERS,
BY REGION, 2019–2026 (USD MILLION) 125
9.4 MEDICAL SPAS & AESTHETIC CLINICS 125
9.4.1 MEDICAL SPAS & AESTHETIC CLINICS OFFER ABLATION SERVICES FOR ENHANCING THE BEAUTY AND OVERALL WELLNESS OF THE BODY 125
TABLE 68 ABLATION TECHNOLOGY MARKET FOR MEDICAL SPAS & AESTHETIC CLINICS, BY REGION, 2019–2026 (USD MILLION) 126
9.5 OTHER END USERS 126
TABLE 69 ABLATION TECHNOLOGY MARKET FOR OTHER END USERS,
BY REGION, 2019–2026 (USD MILLION) 126
10 ABLATION TECHNOLOGY MARKET, BY REGION 127
10.1 INTRODUCTION 128
TABLE 70 ABLATION TECHNOLOGY MARKET, BY REGION, 2019–2026 (USD MILLION) 128
10.2 NORTH AMERICA 128
FIGURE 23 NORTH AMERICA: ABLATION TECHNOLOGY MARKET SNAPSHOT 129
TABLE 71 NORTH AMERICA: ABLATION TECHNOLOGY MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 129
TABLE 72 NORTH AMERICA: ABLATION TECHNOLOGY MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 130
TABLE 73 NORTH AMERICA: RADIOFREQUENCY ABLATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 130
TABLE 74 NORTH AMERICA: LASER/LIGHT ABLATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 131
TABLE 75 NORTH AMERICA: ULTRASOUND ABLATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 131
TABLE 76 NORTH AMERICA: ELECTRICAL ABLATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 131
TABLE 77 NORTH AMERICA: CRYOABLATION DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 132
TABLE 78 NORTH AMERICA: ABLATION TECHNOLOGY MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 132
TABLE 79 NORTH AMERICA: ABLATION TECHNOLOGY MARKET, BY END USER,
2019–2026 (USD MILLION) 133
10.2.1 US 133
10.2.1.1 The rising prevalence of cancer and CVD will propel market growth 133
TABLE 80 US: ABLATION TECHNOLOGY MARKET, BY TYPE, 2019–2026 (USD MILLION) 134
10.2.2 CANADA 134
10.2.2.1 The high burden of cancer supports market growth 134
TABLE 81 CANADA: ABLATION TECHNOLOGY MARKET, BY TYPE,
2019–2026 (USD MILLION) 135
10.3 EUROPE 135
TABLE 82 EUROPE: ABLATION TECHNOLOGY MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 136
TABLE 83 EUROPE: ABLATION TECHNOLOGY MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 136
TABLE 84 EUROPE: RADIOFREQUENCY ABLATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 137
TABLE 85 EUROPE: LASER/LIGHT ABLATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 137
TABLE 86 EUROPE: ULTRASOUND ABLATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 137
TABLE 87 EUROPE: ELECTRICAL ABLATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 138
TABLE 88 EUROPE: CRYOABLATION DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 138
TABLE 89 EUROPE: ABLATION TECHNOLOGY MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 139
TABLE 90 EUROPE: ABLATION TECHNOLOGY MARKET, BY END USER,
2019–2026 (USD MILLION) 139
10.3.1 GERMANY 139
10.3.1.1 Highly developed healthcare infrastructure and rising disease incidence ensure strong growth prospects 139
TABLE 91 GERMANY: ABLATION TECHNOLOGY MARKET, BY TYPE,
2019–2026 (USD MILLION) 140
10.3.2 FRANCE 140
10.3.2.1 Growing geriatric population to support market growth in France 140
TABLE 92 FRANCE: ABLATION TECHNOLOGY MARKET, BY TYPE,
2019–2026 (USD MILLION 141
10.3.3 UK 141
10.3.3.1 Rising geriatric population is supporting the market growth in the UK 141
TABLE 93 UK: ABLATION TECHNOLOGY MARKET, BY TYPE, 2019–2026 (USD MILLION) 142
10.3.4 ITALY 142
10.3.4.1 Rising awareness to support market growth 142
TABLE 94 ITALY: ABLATION TECHNOLOGY MARKET, BY TYPE,
2019–2026 (USD MILLION) 143
10.3.5 SPAIN 143
10.3.5.1 Increasing government funding for research to support market growth 143
TABLE 95 SPAIN: ABLATION TECHNOLOGY MARKET, BY TYPE,
2019–2026 (USD MILLION) 144
10.3.6 REST OF EUROPE 144
TABLE 96 ROE: ABLATION TECHNOLOGY MARKET, BY TYPE, 2019–2026 (USD MILLION) 145
10.4 ASIA PACIFIC 146
FIGURE 24 ASIA PACIFIC: ABLATION TECHNOLOGY MARKET SNAPSHOT 146
TABLE 97 APAC: ABLATION TECHNOLOGY MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 147
TABLE 98 APAC: ABLATION TECHNOLOGY MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 147
TABLE 99 APAC: RADIOFREQUENCY ABLATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 148
TABLE 100 APAC: LASER/LIGHT ABLATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 148
TABLE 101 APAC: ULTRASOUND ABLATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 148
TABLE 102 APAC: ELECTRICAL ABLATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 149
TABLE 103 APAC: CRYOABLATION DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 149
TABLE 104 APAC: ABLATION TECHNOLOGY MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 150
TABLE 105 APAC: ABLATION TECHNOLOGY MARKET, BY END USER,
2019–2026 (USD MILLION) 150
10.4.1 JAPAN 151
10.4.1.1 Presence of universal healthcare reimbursement scenario and growing geriatric population—key factors driving market growth 151
TABLE 106 JAPAN: ABLATION TECHNOLOGY MARKET, BY TYPE,
2019–2026 (USD MILLION) 151
10.4.2 CHINA 152
10.4.2.1 Increasing patient pool and government initiatives for healthcare development are fueling the market growth 152
TABLE 107 CHINA: ABLATION TECHNOLOGY MARKET, BY TYPE,
2019–2026 (USD MILLION) 152
10.4.3 INDIA 153
10.4.3.1 Ongoing modernization and infrastructure development in India to support the market growth 153
TABLE 108 INDIA: ABLATION TECHNOLOGY MARKET, BY TYPE,
2019–2026 (USD MILLION) 153
10.4.4 AUSTRALIA 153
10.4.4.1 Rising research investments and awareness campaigns are the key factors supporting market growth 153
TABLE 109 AUSTRALIA: ABLATION TECHNOLOGY MARKET, BY TYPE,
2019–2026 (USD MILLION) 154
10.4.5 SOUTH KOREA 154
10.4.5.1 Rising R&D and promising clinical trials in the country to positively impact market growth 154
TABLE 110 SOUTH KOREA: ABLATION TECHNOLOGY MARKET, BY TYPE,
2019–2026 (USD MILLION) 155
10.4.6 REST OF ASIA PACIFIC 155
TABLE 111 ROAPAC: ABLATION TECHNOLOGY MARKET, BY TYPE,
2019–2026 (USD MILLION) 155
10.5 LATIN AMERICA 156
TABLE 112 LATAM: ABLATION TECHNOLOGY MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 156
TABLE 113 LATAM: ABLATION TECHNOLOGY MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 156
TABLE 114 LATAM: RADIOFREQUENCY ABLATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 157
TABLE 115 LATAM: LASER/LIGHT ABLATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 157
TABLE 116 LATAM: ULTRASOUND ABLATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 157
TABLE 117 LATAM: ELECTRICAL ABLATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 158
TABLE 118 LATAM: CRYOABLATION DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 158
TABLE 119 LATAM: ABLATION TECHNOLOGY MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 159
TABLE 120 LATAM: ABLATION TECHNOLOGY MARKET, BY END USER,
2019–2026 (USD MILLION) 159
10.5.1 BRAZIL 160
10.5.1.1 Brazil is a key market in Latin America owing to the modernization of healthcare facilities 160
TABLE 121 BRAZIL: ABLATION TECHNOLOGY MARKET, BY TYPE,
2019–2026 (USD MILLION) 160
10.5.2 MEXICO 160
10.5.2.1 Availability of advanced care and increasing awareness programs are fueling market growth in Mexico 160
TABLE 122 MEXICO: ABLATION TECHNOLOGY MARKET, BY TYPE,
2019–2026 (USD MILLION) 161
10.5.3 REST OF LATIN AMERICA 161
TABLE 123 ROE: ABLATION TECHNOLOGY MARKET, BY TYPE,
2019–2026 (USD MILLION) 162
10.6 MIDDLE EAST & AFRICA 162
10.6.1 IMPROVING HEALTHCARE INFRASTRUCTURE AND INCREASING PUBLIC-PRIVATE INVESTMENTS TO DRIVE MARKET GROWTH IN THE MEA 162
TABLE 124 MEA: ABLATION TECHNOLOGY MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 163
TABLE 125 MEA: RADIOFREQUENCY ABLATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 163
TABLE 126 MEA: LASER/LIGHT ABLATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 164
TABLE 127 MEA: ULTRASOUND ABLATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 164
TABLE 128 MEA: ELECTRICAL ABLATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 164
TABLE 129 MEA: CRYOABLATION DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 165
TABLE 130 MEA: ABLATION TECHNOLOGY MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 165
TABLE 131 MEA: ABLATION TECHNOLOGY MARKET, BY END USER,
2019–2026 (USD MILLION) 166
11 COMPETITIVE LANDSCAPE 167
11.1 OVERVIEW 167
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 167
FIGURE 25 OVERVIEW OF STRATEGIES ADOPTED BY KEY ABLATION TECHNOLOGY PROVIDERS 168
11.3 REVENUE SHARE ANALYSIS 169
FIGURE 26 REVENUE SHARE ANALYSIS OF THE TOP PLAYERS IN THE ABLATION TECHNOLOGY MARKET 169
11.4 MARKET SHARE ANALYSIS 170
FIGURE 27 MEDTRONIC HELD THE LEADING POSITION IN
THE ABLATION TECHNOLOGY MARKET IN 2020 170
TABLE 132 ABLATION TECHNOLOGY MARKET: DEGREE OF COMPETITION 170
11.5 COMPANY EVALUATION QUADRANT (MAJOR PLAYERS) 171
11.5.1 STARS 171
11.5.2 PERVASIVE PLAYERS 171
11.5.3 EMERGING LEADERS 171
11.5.4 PARTICIPANTS 171
FIGURE 28 ABLATION TECHNOLOGY MARKET: COMPANY EVALUATION QUADRANT, 2020 172
11.6 COMPANY EVALUATION QUADRANT (SMES/START-UPS) 172
11.6.1 PROGRESSIVE COMPANIES 172
11.6.2 STARTING BLOCKS 172
11.6.3 RESPONSIVE COMPANIES 173
11.6.4 DYNAMIC COMPANIES 173
FIGURE 29 ABLATION TECHNOLOGY MARKET: COMPANY EVALUATION
QUADRANT FOR SMES/START-UPS, 2020 173
11.7 COMPETITIVE BENCHMARKING 174
FIGURE 30 PRODUCT AND REGIONAL FOOTPRINT ANALYSIS OF THE
TOP PLAYERS IN THE ABLATION TECHNOLOGY MARKET 174
TABLE 133 COMPANY APPLICATION FOOTPRINT 174
TABLE 134 COMPANY REGIONAL FOOTPRINT 175
11.8 COMPETITIVE SCENARIO AND TRENDS 175
11.8.1 PRODUCT LAUNCHES & APPROVALS 175
11.8.2 DEALS 176
11.8.3 OTHER DEVELOPMENTS 176
12 COMPANY PROFILES 177
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1 KEY PLAYERS 177
12.1.1 MEDTRONIC 177
TABLE 135 MEDTRONIC: BUSINESS OVERVIEW 177
FIGURE 31 MEDTRONIC: COMPANY SNAPSHOT 178
TABLE 136 MEDTRONIC: PRODUCT OFFERINGS 178
12.1.2 JOHNSON & JOHNSON 182
TABLE 137 JOHNSON & JOHNSON: BUSINESS OVERVIEW 182
FIGURE 32 JOHNSON & JOHNSON: COMPANY SNAPSHOT 183
TABLE 138 JOHNSON & JOHNSON: PRODUCT OFFERINGS 183
12.1.3 ABBOTT LABORATORIES 186
TABLE 139 ABBOTT LABORATORIES: BUSINESS OVERVIEW 186
FIGURE 33 ABBOTT LABORATORIES: COMPANY SNAPSHOT 186
TABLE 140 ABBOTT LABORATORIES: PRODUCT OFFERINGS 187
12.1.4 BOSTON SCIENTIFIC CORPORATION 188
TABLE 141 BOSTON SCIENTIFIC CORPORATION: BUSINESS OVERVIEW 188
FIGURE 34 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT 189
TABLE 142 BOSTON SCIENTIFIC CORPORATION: PRODUCT OFFERINGS 189
12.1.5 ANGIODYNAMICS 191
TABLE 143 ANGIODYNAMICS: BUSINESS OVERVIEW 191
FIGURE 35 ANGIODYNAMICS: COMPANY SNAPSHOT 192
TABLE 144 ANGIODYNAMICS: PRODUCT OFFERINGS 192
12.1.6 ATRICURE 194
TABLE 145 ATRICURE: BUSINESS OVERVIEW 194
FIGURE 36 ATRICURE: COMPANY SNAPSHOT 194
TABLE 146 ATRICURE: PRODUCT OFFERINGS 194
12.1.7 CONMED CORPORATION 196
TABLE 147 CONMED: BUSINESS OVERVIEW 196
FIGURE 37 CONMED CORPORATION: COMPANY SNAPSHOT 197
TABLE 148 CONMED: PRODUCT OFFERINGS 197
12.1.8 OLYMPUS CORPORATION 198
TABLE 149 OLYMPUS CORPORATION: BUSINESS OVERVIEW 198
FIGURE 38 OLYMPUS CORPORATION: COMPANY SNAPSHOT 199
TABLE 150 OLYMPUS CORPORATION: PRODUCT OFFERINGS 199
12.1.9 SMITH & NEPHEW 201
TABLE 151 SMITH & NEPHEW: BUSINESS OVERVIEW 201
FIGURE 39 SMITH & NEPHEW: COMPANY SNAPSHOT 202
TABLE 152 SMITH & NEPHEW: PRODUCT OFFERINGS 202
12.1.10 STRYKER CORPORATION 203
TABLE 153 STRYKER: BUSINESS OVERVIEW 203
FIGURE 40 STRYKER CORPORATION: COMPANY SNAPSHOT 204
TABLE 154 STRYKER: PRODUCT OFFERINGS 204
12.1.11 DORNIER MEDTECH 206
TABLE 155 DORNIER MEDTECH: BUSINESS OVERVIEW 206
TABLE 156 DORNIER MEDTECH: PRODUCT OFFERINGS 206
12.1.12 CYNOSURE 208
TABLE 157 CYNOSURE: BUSINESS OVERVIEW 208
TABLE 158 CYNOSURE: PRODUCT OFFERINGS 208
12.1.13 VARIAN MEDICAL SYSTEMS 209
TABLE 159 VARIAN MEDICAL SYSTEMS: BUSINESS OVERVIEW 209
FIGURE 41 VARIAN MEDICAL SYSTEMS.: COMPANY SNAPSHOT 210
TABLE 160 VARIAN MEDICAL SYSTEMS: PRODUCT OFFERINGS 210
12.1.14 INMODE 213
TABLE 161 INMODE: BUSINESS OVERVIEW 213
FIGURE 42 INMODE: COMPANY SNAPSHOT 213
TABLE 162 INMODE: PRODUCT OFFERINGS 214
12.2 OTHER COMPANIES 216
12.2.1 EDAP TMS 216
12.2.2 LUMENIS 216
12.2.3 ARTHREX 217
12.2.4 ICECURE 217
12.2.5 MERIT MEDICAL 218
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX 219
13.1 DISCUSSION GUIDE 219
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 225
13.3 AVAILABLE CUSTOMIZATIONS 227
13.4 RELATED REPORTS 227
13.5 AUTHOR DETAILS 228

Lateral Flow Assay Components Market by Type, Application Type (Clinical Testing (Infectious, Cardiac Marker Test) Veterinary, Food Safety), Technique...

Publisher:        MarketsandMarkets

# of Pages:        224

Rating: 

1 User License $4,950

Publication Date:  April, 2022

Price:       $4,950 / User License




1 INTRODUCTION 33
1.1 OBJECTIVES OF THE STUDY 33
1.2 MARKET DEFINITION 33
1.2.1 CATEGORY-WISE INCLUSIONS AND EXCLUSIONS
IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 33
1.3 MARKET SCOPE 34
1.3.1 MARKETS COVERED 34
FIGURE 1 LATERAL FLOW ASSAY COMPONENTS MARKET SEGMENTATION 34
1.3.2 YEARS CONSIDERED FOR THE STUDY 35
1.4 CURRENCY 35
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 35
1.5 STAKEHOLDERS 35
2 RESEARCH METHODOLOGY 36
2.1 RESEARCH APPROACH 36
FIGURE 2 RESEARCH DESIGN 36
2.1.1 SECONDARY DATA 36
2.1.1.1 Key data from secondary sources 37
2.1.2 PRIMARY DATA 38
2.1.2.1 Primary sources 38
2.1.2.2 Key data from primary sources 39
2.1.2.3 Breakdown of primaries 39
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE):
BY COMPANY TYPE, DESIGNATION, AND REGION 39
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION 40
2.2 MARKET SIZE ESTIMATION 40
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2021) 41
FIGURE 6 SUPPLY-SIDE ANALYSIS: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 42
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 44
FIGURE 7 DATA TRIANGULATION METHODOLOGY 45
2.4 KEY INDUSTRY INSIGHTS 46
2.5 LIMITATIONS 46
2.5.1 METHODOLOGY-RELATED LIMITATIONS 46
2.6 RISK ASSESSMENT 47
2.7 ASSUMPTIONS FOR THE STUDY 47
 
3 EXECUTIVE SUMMARY 48
FIGURE 8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2022 VS. 2027 (USD MILLION) 48
FIGURE 9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2022 VS. 2027 (USD MILLION) 49
FIGURE 10 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2022 VS. 2027 (USD MILLION) 50
FIGURE 11 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2022 VS. 2027 (USD MILLION) 51
FIGURE 12 GEOGRAPHICAL SNAPSHOT OF THE LATERAL FLOW ASSAY COMPONENTS MARKET 52
4 PREMIUM INSIGHTS 53
4.1 LATERAL FLOW ASSAY COMPONENTS MARKET OVERVIEW 53
FIGURE 13 RISING NUMBER OF LOCAL MANUFACTURERS FOR COMPONENTS IS DRIVING THE GROWTH OF THE LATERAL FLOW ASSAY COMPONENTS MARKET 53
4.2 REGIONAL MIX: LATERAL FLOW ASSAY COMPONENTS MARKET 54
FIGURE 14 APAC TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 54
4.3 ASIA PACIFIC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE AND COUNTRY 55
FIGURE 15 MEMBRANES ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA PACIFIC MARKET IN 2021 55
4.4 LATERAL FLOW ASSAY COMPONENTS MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES 56
4.5 LATERAL FLOW ASSAY COMPONENTS MARKET: DEVELOPED VS. DEVELOPING COUNTRIES 56
5 MARKET OVERVIEW 57
5.1 INTRODUCTION 57
5.2 MARKET DYNAMICS: IMPACT ANALYSIS 57
5.2.1 DRIVERS 58
5.2.1.1 Growing demand for lateral flow assay kits due
to the COVID-19 pandemic 58
5.2.1.2 Growing usage of home-based lateral flow assay devices 58
5.2.1.3 Growing demand for point-of-care testing 58
5.2.1.4 Increasing public-private investments to develop lateral flow assays 59
5.2.2 RESTRAINTS 59
5.2.2.1 Availability of alternative diagnostic technologies 59
5.2.3 OPPORTUNITIES 59
5.2.3.1 Evolving applications of lateral flow assays 59
5.2.4 CHALLENGES 60
5.2.4.1 Requirement of specialized storage and shipping facilities for membranes 60
5.3 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 60
5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES (YC-YCC) IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 60
FIGURE 16 YC–YCC SHIFT IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 61
5.5 AVERAGE SELLING PRICE TREND 61
TABLE 2 AVERAGE SELLING PRICE OF LATERAL FLOW ASSAY COMPONENTS,
BY REGION, 2021 (USD) 61
5.6 ECOSYSTEM MARKET MAP 62
FIGURE 17 ECOSYSTEM: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 62
5.7 PATENT ANALYSIS 63
5.7.1 PATENT PUBLICATION TRENDS FOR LATERAL FLOW ASSAYS 63
FIGURE 18 GLOBAL PATENT PUBLICATION TRENDS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET, 2016–2021 64
5.7.2 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 64
FIGURE 19 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR LATERAL FLOW ASSAYS COMPONENTS, 2016–2021 64
5.8 VALUE CHAIN ANALYSIS 65
5.9 REGULATORY LANDSCAPE 66
TABLE 3 REGULATORY STANDARDS/APPROVALS REQUIRED FOR LATERAL FLOW IMMUNOASSAY PRODUCTS, BY COUNTRY/REGION 66
5.9.1 NORTH AMERICA 66
5.9.2 EUROPE 67
5.9.3 ASIA PACIFIC 67
5.9.3.1 India 67
5.9.3.2 China 67
5.9.3.3 Japan 68
5.10 TECHNOLOGY ANALYSIS 69
5.10.1 KEY TECHNOLOGY: LATERAL FLOW ASSAYS 69
5.11 KEY CONFERENCES & EVENTS DURING 2021–2023 69
TABLE 4 LATERAL FLOW ASSAY COMPONENTS MARKET: DETAILED LIST OF CONFERENCES & EVENTS 69
5.12 KEY STAKEHOLDERS & BUYING CRITERIA 70
5.12.1 KEY STAKEHOLDERS IN THE BUYING PROCESS 70
FIGURE 20 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS FOR THE TOP 3 APPLICATIONS 70
TABLE 5 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS FOR THE TOP 3 APPLICATIONS 70
5.12.2 BUYING CRITERIA 71
FIGURE 21 KEY BUYING CRITERIA FOR THE TOP 3 APPLICATIONS 71
TABLE 6 KEY BUYING CRITERIA FOR THE TOP 3 APPLICATIONS 71
5.13 PORTER’S FIVE FORCES ANALYSIS 72
TABLE 7 LATERAL FLOW ASSAY COMPONENTS MARKET:
PORTER’S FIVE FORCES ANALYSIS 72
5.13.1 THREAT FROM NEW ENTRANTS 72
5.13.2 THREAT FROM SUBSTITUTES 72
5.13.3 BARGAINING POWER OF BUYERS 73
5.13.4 BARGAINING POWER OF SUPPLIERS 73
5.13.5 INTENSITY OF COMPETITIVE RIVALRY 73
6 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE 74
6.1 INTRODUCTION 75
TABLE 8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 75
6.2 MEMBRANES 75
TABLE 9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE,
2020–2027 (USD MILLION) 76
TABLE 10 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEMBRANES,
BY COUNTRY, 2020–2027 (USD MILLION) 76
6.2.1 NITROCELLULOSE MEMBRANES 77
6.2.1.1 Advantages of nitrocellulose membranes such as high protein-binding affinity and compatibility with a wide range of detection methods to drive market growth 77
TABLE 11 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES, BY COUNTRY, 2020–2027 (USD MILLION) 77
TABLE 12 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES (1 X 1 M SHEETS), BY REGION, 2020–2027 (IN THOUSANDS) 78
TABLE 13 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES (20 MM X 1 M ROLLS), BY REGION, 2020–2027 (IN MILLIONS) 78
6.2.2 OTHER MEMBRANES 78
TABLE 14 LATERAL FLOW ASSAY COMPONENTS MARKET FOR OTHER MEMBRANES,
BY COUNTRY, 2020–2027 (USD MILLION) 79
6.3 PADS 80
TABLE 15 EXAMPLES OF DIFFERENT MATERIALS USED IN MANUFACTURING LATERAL FLOW ASSAY PADS 80
TABLE 16 LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 80
TABLE 17 LATERAL FLOW ASSAY COMPONENTS MARKET FOR PADS, BY COUNTRY, 2020–2027 (USD MILLION) 81
6.3.1 SAMPLE PADS 81
6.3.1.1 Ability to promote even and controlled distribution of samples to drive market growth 81
TABLE 18 LATERAL FLOW ASSAY COMPONENTS MARKET FOR SAMPLE PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 82
6.3.2 CONJUGATE PADS 82
6.3.2.1 Conjugate pads play an important role in controlling the performance of lateral flow immunoassays 82
TABLE 19 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CONJUGATE PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 83
6.3.3 ABSORBENT PADS 84
6.3.3.1 Absorbent pads prevent backflow—a key factor driving market growth 84
TABLE 20 LATERAL FLOW ASSAY COMPONENTS MARKET FOR ABSORBENT PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 84
6.4 OTHER COMPONENTS 84
TABLE 21 OTHER LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 85
7 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION 86
7.1 INTRODUCTION 87
TABLE 22 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 87
7.2 CLINICAL TESTING 87
TABLE 23 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 88
TABLE 24 LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS,
BY COUNTRY, 2020–2027 (USD MILLION) 88
7.2.1 INFECTIOUS DISEASE TESTING 89
7.2.1.1 Rising demand for infectious disease testing in emerging markets to drive market growth 89
TABLE 25 LATERAL FLOW ASSAY COMPONENTS MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 89
7.2.2 PREGNANCY & FERTILITY TESTING 90
7.2.2.1 Growing infertility levels due to changing lifestyles—a key factor driving market growth 90
TABLE 26 LATERAL FLOW ASSAY COMPONENTS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 90
7.2.3 CARDIAC MARKER TESTING 91
7.2.3.1 Rising prevalence of cardiovascular diseases and growing government support to drive growth in this market segment 91
TABLE 27 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CARDIAC MARKER TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 92
7.2.4 CHOLESTEROL TESTING/LIPID PROFILING 92
7.2.4.1 Growing prevalence of obesity and CVD—
a key factor driving market growth 92
TABLE 28 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CHOLESTEROL TESTING/LIPID PROFILING, BY COUNTRY, 2020–2027 (USD MILLION) 93
7.2.5 DRUGS-OF-ABUSE TESTING 93
7.2.5.1 Technological advancements and a growing focus on workplace
drug testing are driving market growth 93
TABLE 29 LATERAL FLOW ASSAY COMPONENTS MARKET FOR DRUGS-OF-ABUSE TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 94
7.2.6 OTHER CLINICAL TESTING APPLICATIONS 94
TABLE 30 LATERAL FLOW ASSAY COMPONENTS MARKET FOR OTHER CLINICAL TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 95
7.3 VETERINARY DIAGNOSTICS 95
7.3.1 INFECTIOUS DISEASE OUTBREAKS (PARTICULARLY IN LARGE LIVESTOCK ANIMALS) TO DRIVE MARKET GROWTH 95
TABLE 31 LATERAL FLOW ASSAY COMPONENTS MARKET FOR VETERINARY DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 96
7.4 FOOD SAFETY & ENVIRONMENTAL TESTING 96
7.4.1 HIGH SENSITIVITY AND EASE OF USE ARE KEY FACTORS DRIVING THE DEMAND FOR LATERAL FLOW ASSAYS FOR FOOD SAFETY TESTING 96
TABLE 32 LATERAL FLOW ASSAY COMPONENTS MARKET FOR FOOD SAFETY & ENVIRONMENTAL TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 97
7.5 DRUG DEVELOPMENT & QUALITY TESTING 97
7.5.1 INCREASING FOCUS ON PRODUCT SAFETY AND QUALITY ASSURANCE TO DRIVE MARKET GROWTH IN THE COMING YEARS 97
TABLE 33 LATERAL FLOW ASSAY COMPONENTS MARKET FOR DRUG DEVELOPMENT & QUALITY TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 98
8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE 99
8.1 INTRODUCTION 100
TABLE 34 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 100
8.2 SANDWICH ASSAYS 100
8.2.1 SANDWICH ASSAYS PROVIDE HIGHER LEVELS OF ASSAY SENSITIVITY AND SPECIFICITY THAN OTHER ASSAY TECHNIQUES—A KEY FACTOR DRIVING GROWTH IN THIS MARKET SEGMENT 100
TABLE 35 LATERAL FLOW ASSAY COMPONENTS MARKET FOR SANDWICH ASSAYS,
BY COUNTRY, 2020–2027 (USD MILLION) 101
8.3 COMPETITIVE ASSAYS 101
8.3.1 REDUCED SELECTIVITY AND SENSITIVITY OF COMPETITIVE ASSAYS IN RELATION TO SANDWICH ASSAYS COULD HAMPER MARKET GROWTH 101
TABLE 36 LATERAL FLOW ASSAY COMPONENTS MARKET FOR COMPETITIVE ASSAYS,
BY COUNTRY, 2020–2027 (USD MILLION) 102
8.4 MULTIPLEX DETECTION ASSAYS 102
8.4.1 INCREASING ADOPTION OF MULTI-ANALYTE ASSAYS AMONG CLINICIANS TO DRIVE MARKET GROWTH 102
TABLE 37 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MULTIPLEX DETECTION ASSAYS, BY COUNTRY, 2020–2027 (USD MILLION) 103
9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER 104
9.1 INTRODUCTION 105
TABLE 38 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 105
9.2 MEDICAL DEVICE MANUFACTURING COMPANIES 105
9.2.1 INCREASING USE OF POC TESTS IS DRIVING THE ADOPTION OF LATERAL FLOW ASSAY COMPONENTS AMONG MEDICAL DEVICE MANUFACTURING COMPANIES 105
TABLE 39 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEDICAL DEVICE MANUFACTURING COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION) 106
9.3 MEDICAL DEVICE CONTRACT MANUFACTURING COMPANIES 106
9.3.1 GROWING INCLINATION TOWARD FAST AND EARLY DIAGNOSIS, ESPECIALLY IN RELATION TO THE CURRENT COVID-19 SCENARIO, WILL DRIVE MARKET GROWTH 106
TABLE 40 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEDICAL DEVICE CONTRACT MANUFACTURING COMPANIES, BY COUNTRY,
2020–2027 (USD MILLION) 107
 
10 LATERAL FLOW ASSAY COMPONENTS MARKET, BY REGION 108
10.1 INTRODUCTION 109
FIGURE 22 CHINA TO REGISTER THE HIGHEST GROWTH IN THE LATERAL FLOW ASSAY COMPONENTS MARKET DURING THE FORECAST PERIOD 109
TABLE 41 LATERAL FLOW ASSAY COMPONENTS MARKET, BY REGION,
2020–2027 (USD MILLION) 110
10.2 NORTH AMERICA 110
TABLE 42 NORTH AMERICA: MACROECONOMIC INDICATORS 110
FIGURE 23 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET SNAPSHOT 111
TABLE 43 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY COUNTRY, 2020–2027 (USD MILLION) 112
TABLE 44 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 112
TABLE 45 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 112
TABLE 46 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY PAD TYPE, 2020–2027 (USD MILLION) 113
TABLE 47 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 113
TABLE 48 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 114
TABLE 49 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 114
TABLE 50 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 115
10.2.1 US 115
10.2.1.1 Increasing R&D investments and venture capital funding from both large and small firms towards the development of lateral flow assay diagnostics to drive market growth in the US 115
TABLE 51 US: MACROECONOMIC INDICATORS 116
TABLE 52 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 116
TABLE 53 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 116
TABLE 54 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 117
TABLE 55 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 117
TABLE 56 US: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 118
TABLE 57 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 118
TABLE 58 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 119
10.2.2 CANADA 119
10.2.2.1 Lateral flow assay components market in Canada is estimated to grow at a relatively lower rate than the US 119
TABLE 59 CANADA: MACROECONOMIC INDICATORS 119
TABLE 60 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 120
TABLE 61 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 120
TABLE 62 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 120
TABLE 63 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 121
TABLE 64 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 121
TABLE 65 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 122
TABLE 66 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 122
10.3 EUROPE 122
TABLE 67 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 123
TABLE 68 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 123
TABLE 69 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 123
TABLE 70 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 124
TABLE 71 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 124
TABLE 72 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 125
TABLE 73 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 125
TABLE 74 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 126
10.3.1 GERMANY 126
10.3.1.1 Growing demand for POC testing to drive the lateral flow assay components market in Germany 126
TABLE 75 GERMANY: MACROECONOMIC INDICATORS 126
TABLE 76 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 127
TABLE 77 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 127
TABLE 78 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 127
TABLE 79 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 128
TABLE 80 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 128
TABLE 81 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 129
TABLE 82 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 129
10.3.2 FRANCE 129
10.3.2.1 High prevalence of age-related chronic diseases and infectious diseases to drive market growth in France 129
TABLE 83 FRANCE: MACROECONOMIC INDICATORS 130
TABLE 84 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 130
TABLE 85 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 130
TABLE 86 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 131
TABLE 87 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 131
TABLE 88 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 132
TABLE 89 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 132
TABLE 90 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 133
10.3.3 UK 133
10.3.3.1 Severe impact of the second wave of COVID-19 in the first half of 2021 resulted in higher adoption of rapid COVID tests in the UK 133
TABLE 91 UK: MACROECONOMIC INDICATORS 134
TABLE 92 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 134
TABLE 93 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 134
TABLE 94 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 135
TABLE 95 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 135
TABLE 96 UK: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 136
TABLE 97 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 136
TABLE 98 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 137
10.3.4 ITALY 137
10.3.4.1 Growing initiatives towards decentralization of medical services in Italy are contributing to the market growth in the country 137
TABLE 99 ITALY: MACROECONOMIC INDICATORS 137
TABLE 100 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 138
TABLE 101 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 138
TABLE 102 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 138
TABLE 103 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 139
TABLE 104 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 139
TABLE 105 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 140
TABLE 106 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 140
10.3.5 SPAIN 140
10.3.5.1 Increasing focus of international organizations and domestic players on the development of POC products in the country to drive market growth 140
TABLE 107 SPAIN: MACROECONOMIC INDICATORS 141
TABLE 108 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 141
TABLE 109 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 142
TABLE 110 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 142
TABLE 111 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 142
TABLE 112 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 143
TABLE 113 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 143
TABLE 114 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 144
10.3.6 REST OF EUROPE 144
TABLE 115 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 144
TABLE 116 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 145
TABLE 117 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 145
TABLE 118 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 145
TABLE 119 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 146
TABLE 120 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 146
TABLE 121 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 147
10.4 ASIA PACIFIC 147
FIGURE 24 ASIA PACIFIC: LATERAL FLOW ASSAY COMPONENTS MARKET SNAPSHOT 148
TABLE 122 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 149
TABLE 123 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 149
TABLE 124 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 149
TABLE 125 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 150
TABLE 126 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 150
TABLE 127 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 151
TABLE 128 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 151
TABLE 129 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 152
10.4.1 CHINA 152
10.4.1.1 Higher exports of lateral flow assay components during the COVID-19 pandemic to drive market growth in the country 152
TABLE 130 CHINA: MACROECONOMIC INDICATORS 153
TABLE 131 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 153
TABLE 132 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 153
TABLE 133 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 154
TABLE 134 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 154
TABLE 135 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 155
TABLE 136 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 155
TABLE 137 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 156
10.4.2 JAPAN 156
10.4.2.1 Increasing prevalence of age-related illnesses driving the growth of the lateral flow assay components market in Japan 156
TABLE 138 JAPAN: MACROECONOMIC INDICATORS 157
TABLE 139 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 157
TABLE 140 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 157
TABLE 141 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 158
TABLE 142 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 158
TABLE 143 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 159
TABLE 144 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 159
TABLE 145 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 160
10.4.3 INDIA 160
10.4.3.1 Increasing number of local manufacturers, growing healthcare concerns, and rising income levels to propel the growth of this market 160
TABLE 146 INDIA: MACROECONOMIC INDICATORS 160
TABLE 147 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 161
TABLE 148 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 161
TABLE 149 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 161
TABLE 150 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 162
TABLE 151 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 162
TABLE 152 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 163
TABLE 153 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 163
10.4.4 AUSTRALIA 164
10.4.4.1 Increasing prevalence of infectious diseases, especially influenza, to drive the growth of the lateral flow assay components market in Australia 164
TABLE 154 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 164
TABLE 155 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 164
TABLE 156 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 165
TABLE 157 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 165
TABLE 158 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 166
TABLE 159 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 166
TABLE 160 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 167
10.4.5 REST OF ASIA PACIFIC 167
TABLE 161 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 167
TABLE 162 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 168
TABLE 163 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 168
TABLE 164 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 168
TABLE 165 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 169
TABLE 166 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 169
TABLE 167 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 170
 
10.5 LATIN AMERICA 170
10.5.1 HIGH DEMAND FOR HIV POC DEVICES IN THE REGION TO SUPPORT THE GROWTH OF THE MARKET 170
TABLE 168 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 171
TABLE 169 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 171
TABLE 170 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD
TYPE, 2020–2027 (USD MILLION) 171
TABLE 171 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 172
TABLE 172 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 172
TABLE 173 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 173
TABLE 174 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 173
10.6 MIDDLE EAST & AFRICA 173
10.6.1 SIGNIFICANT SUPPORT FROM GOVERNMENTS AND GLOBAL FIRMS TOWARDS EXPANDING HEALTHCARE SERVICES DRIVES THE ADOPTION OF LATERAL FLOW ASSAYS 173
TABLE 175 MIDDLE EAST & AFRICA: MACROECONOMIC INDICATORS 174
TABLE 176 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TYPE, 2020–2027 (USD MILLION) 174
TABLE 177 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 175
TABLE 178 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY PAD TYPE, 2020–2027 (USD MILLION) 175
TABLE 179 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 175
TABLE 180 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 176
TABLE 181 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 176
TABLE 182 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 177
11 COMPETITIVE LANDSCAPE 178
11.1 OVERVIEW 178
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 178
FIGURE 25 OVERVIEW OF STRATEGIES ADOPTED BY MAJOR PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 179
11.3 REVENUE SHARE ANALYSIS FOR KEY PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 179
FIGURE 26 REVENUE SHARE ANALYSIS FOR THE KEY PLAYERS
IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 180
11.4 MARKET SHARE ANALYSIS 180
FIGURE 27 LATERAL FLOW ASSAY COMPONENTS MARKET SHARE ANALYSIS, BY KEY PLAYER (2021) 181
TABLE 183 LATERAL FLOW ASSAY COMPONENTS MARKET: DEGREE OF COMPETITION 182
11.5 R&D ASSESSMENT OF KEY PLAYERS 183
FIGURE 28 R&D EXPENDITURE: MAJOR PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET, 2018 VS. 2020 183
11.6 GEOGRAPHIC REVENUE ASSESSMENT OF KEY PLAYERS 183
FIGURE 29 GEOGRAPHIC REVENUE ASSESSMENT: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 184
11.7 COMPANY EVALUATION QUADRANT 184
11.7.1 STARS 184
11.7.2 PERVASIVE PLAYERS 184
11.7.3 EMERGING LEADERS 185
11.7.4 PARTICIPANTS 185
FIGURE 30 LATERAL FLOW ASSAY COMPONENTS MARKET: COMPANY EVALUATION MATRIX, 2021 185
11.8 COMPETITIVE BENCHMARKING 186
11.8.1 OVERALL COMPANY FOOTPRINT 186
TABLE 184 OVERALL COMPANY FOOTPRINT (17 COMPANIES) 186
TABLE 185 COMPANY FOOTPRINT: BY TYPE (17 COMPANIES) 187
TABLE 186 COMPANY FOOTPRINT: BY REGION (17 COMPANIES) 188
11.9 COMPETITIVE SCENARIO 188
11.9.1 DEALS 189
TABLE 187 DEALS, JANUARY 2019–FEBRUARY 2022 189
11.9.2 OTHER DEVELOPMENTS 189
TABLE 188 OTHER DEVELOPMENTS, JANUARY 2019–FEBRUARY 2022 189
12 COMPANY PROFILES 190
12.1 KEY PLAYERS 190
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 DANAHER CORPORATION (PALL CORPORATION AND CYTIVA LIFE SCIENCE) 190
TABLE 189 DANAHER CORPORATION: BUSINESS OVERVIEW 190
FIGURE 31 DANAHER CORPORATION: COMPANY SNAPSHOT (2020) 191
12.1.2 SARTORIUS STEDIM BIOTECH 195
TABLE 190 SARTORIUS STEDIM BIOTECH: BUSINESS OVERVIEW 195
12.1.3 MERCK KGAA 199
TABLE 191 MERCK KGAA: BUSINESS OVERVIEW 199
FIGURE 33 MERCK KGAA: COMPANY SNAPSHOT (2020) 200
12.1.4 AHLSTROM-MUNKSJÖ 204
TABLE 192 AHLSTROM-MUNKSJÖ: BUSINESS OVERVIEW 204
FIGURE 34 AHLSTROM-MUNKSJÖ: COMPANY SNAPSHOT (2020) 205
12.1.5 ADVANCED MICRODEVICES PVT. LTD. 208
TABLE 193 ADVANCED MICRODEVICES PVT. LTD.: BUSINESS OVERVIEW 208
12.1.6 DCN DIAGNOSTICS 210
TABLE 194 DCN DIAGNOSTICS: BUSINESS OVERVIEW 210
12.2 OTHER PLAYERS 211
12.2.1 FORTIS LIFE SCIENCES 211
TABLE 195 FORTIS LIFE SCIENCES: BUSINESS OVERVIEW 211
12.2.2 HANGZHOU COBETTER FILTRATION EQUIPMENT CO. LTD 212
TABLE 196 HANGZHOU COBETTER FILTRATION EQUIPMENT CO. LTD.:
BUSINESS OVERVIEW 212
12.2.3 AXIVA SICHEM BIOTECH 214
TABLE 197 AXIVA SICHEM BIOTECH: BUSINESS OVERVIEW 214
12.2.4 NUPORE FILTRATION SYSTEM 216
TABLE 198 NUPORE FILTRATION SYSTEM: BUSINESS OVERVIEW 216
12.2.5 BALLYA BIO 217
TABLE 199 BALLYA BIO: BUSINESS OVERVIEW 217
12.2.6 RUNBIO BIOTECH CO. LTD. 219
TABLE 200 RUNBIO BIOTECH CO. LTD.: BUSINESS OVERVIEW 219
12.2.7 NEENAH GESSNER 220
TABLE 201 NEENAH GESSNER: BUSINESS OVERVIEW 220
12.2.8 MAXIM BIOMEDICAL 221
TABLE 202 MAXIM BIOMEDICAL: BUSINESS OVERVIEW 221
12.2.9 CYTODIAGNOSTICS 222
TABLE 203 CYTODIAGNOSTICS: BUSINESS OVERVIEW 222
12.2.10 SENOVA GMBH 223
TABLE 204 SENOVA GMBH: BUSINESS OVERVIEW 223
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX 224
13.1 DISCUSSION GUIDE 224
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 229
13.3 AVAILABLE CUSTOMIZATIONS 231
13.4 RELATED REPORTS 231
13.5 AUTHOR DETAILS 232

US Healthcare Environmental Services Market by Type (Janitorial/Core-Cleaning, Infection Control & Prevention, Front-of-house cleaning & Brand Experie...

Publisher:        MarketsandMarkets

# of Pages:        126

Rating: 

1 User License $4,950

Publication Date:  March, 2022

Price:       $4,950 / User License




1 INTRODUCTION 15
1.1 OBJECTIVES OF THE STUDY 15
1.2 MARKET DEFINITION & SCOPE 15
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 16
1.2.2 MARKET SEGMENTATION 16
FIGURE 1 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET SEGMENTATION 16
1.2.3 YEARS CONSIDERED FOR THE STUDY 17
1.3 CURRENCY 17
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 17
1.4 STAKEHOLDERS 18
2 RESEARCH METHODOLOGY 19
2.1 RESEARCH APPROACH 19
FIGURE 2 RESEARCH DESIGN 19
2.1.1 SECONDARY RESEARCH 20
2.1.1.1 Key data from secondary sources 21
2.1.2 PRIMARY RESEARCH 21
FIGURE 3 PRIMARY SOURCES 22
2.1.2.1 Key data from primary sources 23
2.1.2.2 Insights from primary experts 23
2.1.2.3 Breakdown of primary interviews 24
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE (SUPPLY & DEMAND SIDE) AND DESIGNATION 24
2.2 MARKET SIZE ESTIMATION 25
FIGURE 5 MARKET SIZE APPROACH – REVENUE SHARE ANALYSIS 25
FIGURE 6 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 26
FIGURE 7 DEMAND-SIDE APPROACH 28
2.3 DATA TRIANGULATION 29
FIGURE 8 DATA TRIANGULATION METHODOLOGY 29
2.4 MARKET RANKING ANALYSIS 30
2.5 ASSUMPTIONS FOR THE STUDY 30
2.6 LIMITATIONS 31
2.6.1 METHODOLOGY-RELATED LIMITATIONS 31
2.6.2 SCOPE-RELATED LIMITATIONS 31
2.7 RISK ASSESSMENT 31
TABLE 2 RISK ASSESSMENT: US HEALTHCARE ENVIRONMENTAL SERVICES MARKET 31
 
3 EXECUTIVE SUMMARY 32
FIGURE 9 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION) 32
FIGURE 10 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET,
BY FACILITY TYPE, 2021 VS. 2026 (USD MILLION) 33
4 PREMIUM INSIGHTS 34
4.1 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET OVERVIEW 34
FIGURE 11 STRINGENT REGULATORY GUIDELINES ON INFECTION CONTROL & PREVENTION METHODS IS A KEY FACTOR DRIVING THE MARKET GROWTH 34
4.2 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE AND FACILITY TYPE 35
FIGURE 12 JANITORIAL/CORE-CLEANING SERVICES ACCOUNTED FOR THE LARGEST SHARE OF THE US HEALTHCARE ENVIRONMENTAL SERVICES
MARKET IN 2020 35
4.3 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE (2021–2026) 36
FIGURE 13 ACUTE CARE FACILITIES TO DOMINATE THE US HEALTHCARE ENVIRONMENTAL SERVICES MARKET DURING THE FORECAST PERIOD 36
5 MARKET OVERVIEW 37
5.1 INTRODUCTION 37
5.2 MARKET DYNAMICS 37
TABLE 3 MARKET DYNAMICS: HEALTHCARE ENVIRONMENTAL SERVICES MARKET 37
5.2.1 MARKET DRIVERS 38
5.2.1.1 Increasing prevalence of Hospital-acquired infections (HAIs) 38
5.2.1.2 Rising number of hospital admissions and surgeries 39
TABLE 4 US: PERCENTAGE INCREASE IN THE NUMBER OF SURGERIES PERFORMED 39
FIGURE 14 TOTAL ADMISSIONS IN ALL US HOSPITALS 40
FIGURE 15 TOTAL NUMBER OF HOSPITALS IN THE US 40
5.2.1.3 Shortage of in-house expertise and the rising need to reduce healthcare costs 41
5.2.1.4 Increasing outsourcing of cleaning services 41
5.2.2 MARKET RESTRAINTS 41
5.2.2.1 Healthcare facilities with an in-house EVS department 41
5.2.3 MARKET OPPORTUNITIES 42
5.2.3.1 Sustained acquisitions among strategic & financial buyers 42
TABLE 5 COMPANY ACQUISITIONS 42
5.2.4 MARKET CHALLENGES 42
5.2.4.1 Noncompliance with cleaning standards by EVS providers 42
5.3 INDUSTRY TRENDS 43
5.3.1 EMERGENCE OF NEW SURFACE DISINFECTANTS &
GREEN CLEANING PRODUCTS 43
5.3.2 DISINFECTION ROBOTS 44
5.3.3 MONITORING TOOLS FOR CLEANING QUALITY ASSESSMENT 44
5.4 TECHNOLOGY ANALYSIS 45
TABLE 6 TECHNOLOGY INNOVATION IN THE HEALTHCARE ENVIRONMENTAL
SERVICES MARKET 45
5.5 PATENT ANALYSIS 45
5.5.1 PATENT PUBLICATION TRENDS FOR HEALTHCARE ENVIRONMENTAL SERVICES 46
FIGURE 16 PATENT PUBLICATION TRENDS (JANUARY 2011–DECEMBER 2021) 46
5.5.2 JURISDICTION AND TOP APPLICANT ANALYSIS 47
FIGURE 17 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR HEALTHCARE ENVIRONMENTAL SERVICES PATENTS (JANUARY 2011–JANUARY 2022) 47
FIGURE 18 TOP APPLICANT COUNTRIES/REGIONS FOR HEALTHCARE ENVIRONMENTAL SERVICES PATENTS (JANUARY 2011–JANUARY 2022) 48
TABLE 7 LIST OF PATENTS/PATENT APPLICATIONS IN THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET, 2020–2021 48
5.6 IMPACT OF COVID-19 ON THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET 50
6 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE 51
6.1 INTRODUCTION 52
TABLE 8 US: HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 52
6.2 JANITORIAL SERVICES/CORE-CLEANING SERVICES 52
6.2.1 MANDATORY REGULAR CLEANING AND DISINFECTION OF HEALTHCARE FACILITIES TO DRIVE THE MARKET GROWTH 52
6.3 INFECTION PREVENTION & CONTROL SERVICES 53
TABLE 9 US: INFECTION PREVENTION & CONTROL SERVICE MARKET, BY TYPE,
2019–2026 (USD MILLION) 53
6.3.1 SPECIALIZED CLEANING SERVICES 53
6.3.1.1 Rising adoption of specialized services to reduce HAIs to drive the market growth 53
6.3.2 INFECTION PREVENTION & CONTROL CONSULTATION SERVICES 53
6.3.2.1 The provision of customized environmental services specific
to a healthcare facility ensures market demand 53
6.4 ENHANCED CLEANING TECHNOLOGY 54
6.4.1 RISING DEMAND FOR ADVANCED CLEANING SOLUTIONS TO DRIVE THE SEGMENT GROWTH 54
TABLE 10 EXAMPLES OF COMPANIES PROVIDING TECHNOLOGY & INNOVATION IN HEALTHCARE EVS 54
6.5 FRONT-OF-HOUSE CLEANING AND BRAND EXPERIENCE 56
6.5.1 RISING AWARENESS TOWARDS A CLEAN AND SAFE ENVIRONMENT DURING PANDEMICS TO SUSTAIN THE MARKET GROWTH 56
6.6 OTHER SERVICES 56
 
7 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE 57
7.1 INTRODUCTION 58
FIGURE 19 STATES WITH THE HIGHEST NUMBER OF COVID-19 ADMISSIONS
(FEBRUARY 2022) 58
TABLE 11 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE, 2019–2026 (USD MILLION) 59
7.2 ACUTE-CARE FACILITIES 59
TABLE 12 US: HEALTHCARE ENVIRONMENTAL SERVICES FOR ACUTE-CARE SETTINGS, BY TYPE 2019–2026 (USD MILLION) 59
7.2.1 ACUTE HOSPITALS 60
7.2.1.1 Increasing hospital admissions due to COVID-19 and the rising prevalence of HAIs propel the market growth 60
FIGURE 20 NUMBER OF HAIS REPORTED BY GENERAL ACUTE CARE HOSPITALS
IN THE US (2020) 60
FIGURE 21 HAIS REPORTED BY GENERAL ACUTE CARE HOSPITALS IN THE US (2020) 61
FIGURE 22 HAIS REPORTED BY CRITICAL ACCESS HOSPITALS (CAHS) IN THE US (2018) 61
7.2.2 MILITARY TREATMENT FACILITY 61
7.2.2.1 The increasing number of military ambulatory health services & funding to drive the market growth 61
FIGURE 23 MILITARY HEALTH SYSTEMS FACILITIES IN THE US (2021) 62
7.2.3 CHILDREN’S HOSPITALS 62
7.2.3.1 Rising cases of COVID-19 and infection-related mortality rates among children drive the market growth 62
7.2.4 AMBULATORY SURGERY CENTERS (ASCS) 63
7.2.4.1 ASCs save time and reduce the risk of HAIS; key factor driving the market growth 63
FIGURE 24 US SURGERY CASES BY SETTING: ASC VS. HOPD (2005-2020) 64
7.2.5 ACADEMIC MEDICAL CENTERS (AMCS) 64
7.2.5.1 Healthcare capacity expansion during COVID-19 drives the adoption of healthcare environmental services in AMCs 64
7.3 POST-ACUTE CARE FACILITIES 64
TABLE 13 US: HEALTHCARE ENVIRONMENTAL SERVICES FOR POST-ACUTE CARE SETTINGS, BY TYPE 2019–2026 (USD MILLION) 65
7.3.1 LONG-TERM ACUTE HOSPITALS (LTACH) 65
7.3.1.1 Increasing risk of infection due to prolonged hospital stays to drive the market growth 65
7.3.2 SKILLED NURSING FACILITIES (SNF) 66
7.3.2.1 Increasing admissions of elderly people in skilled nursing facilities to drive the market growth 66
7.3.3 OTHER POST-ACUTE CARE FACILITIES 66
7.4 NON-ACUTE CARE FACILITIES 67
TABLE 14 US: ENVIRONMENTAL SERVICES MARKET FOR NON-ACUTE CARE SETTINGS, BY TYPE, 2019–2026 (USD MILLION) 67
7.4.1 PHYSICIAN’S OFFICES AND CLINICS 67
7.4.1.1 High patient traffic leads to continuous cleaning & maintenance to drive the market growth 67
7.4.2 OTHER NON-ACUTE CARE FACILITIES 68
FIGURE 25 DISTRIBUTION OF INDUSTRY MEDICAL AND HEALTH R&D INVESTMENTS,
BY SEGMENT (2020) 68
8 COMPETITIVE LANDSCAPE 70
8.1 OVERVIEW 70
8.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 70
8.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET 71
8.3 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS 72
8.4 MARKET RANKING ANALYSIS 73
FIGURE 27 US HEALTHCARE ENVIRONMENTAL SERVICE MARKET RANKING,
BY KEY PLAYER, 2020 73
8.5 COMPETITIVE BENCHMARKING 75
TABLE 15 FOOTPRINT OF COMPANIES IN THE HEALTHCARE ENVIRONMENTAL
SERVICES MARKET 75
TABLE 16 SERVICE FOOTPRINT OF COMPANIES 76
TABLE 17 END-USER FOOTPRINT OF COMPANIES 77
8.6 COMPETITIVE LEADERSHIP MAPPING 77
8.6.1 STARS 78
8.6.2 EMERGING LEADERS 78
8.6.3 PERVASIVE PLAYERS 78
8.6.4 PARTICIPANTS 78
FIGURE 28 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET:
COMPETITIVE LEADERSHIP MAPPING (2021) 79
8.7 COMPETITIVE SCENARIO 80
8.7.1 SERVICE APPROVALS/ENHANCEMENTS 80
8.7.2 DEALS 81
TABLE 19 DEALS, 2018–2022 81
8.7.3 OTHER DEVELOPMENTS 82
9 COMPANY PROFILES 83
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
9.1 SODEXO GLOBAL 83
TABLE 21 SODEXO GLOBAL: BUSINESS OVERVIEW 83
FIGURE 29 SODEXO GLOBAL: COMPANY SNAPSHOT (2021) 84
9.2 COMPASS GROUP (CROTHALL HEALTHCARE (US)) 87
TABLE 22 COMPASS GROUP: BUSINESS OVERVIEW 87
FIGURE 30 COMPASS GROUP: COMPANY SNAPSHOT (2021) 88
 
9.3 ARAMARK CORPORATION 90
TABLE 23 ARAMARK CORPORATION: BUSINESS OVERVIEW 90
FIGURE 31 ARAMARK CORPORATION: COMPANY SNAPSHOT (2021) 91
9.4 HOSPITAL HOUSEKEEPING SYSTEMS (HHS) (US) 94
TABLE 24 HOSPITAL HOUSEKEEPING SYSTEMS (HHS): BUSINESS OVERVIEW 94
9.5 HEALTHCARE SERVICES GROUP, INC. 97
TABLE 25 HEALTHCARE SERVICES GROUP, INC.: BUSINESS OVERVIEW 97
FIGURE 32 HEALTHCARE SERVICES GROUP: COMPANY SNAPSHOT (2020) 98
9.6 ABM INDUSTRIES INCORPORATED 100
TABLE 26 ABM INDUSTRIES INCORPORATED: BUSINESS OVERVIEW 100
FIGURE 33 ABM INDUSTRIES INCORPORATED: COMPANY SNAPSHOT (2020) 101
9.7 OCTOCLEAN 103
TABLE 27 OCTOCLEAN: BUSINESS OVERVIEW 103
9.8 SERVICEMASTER CLEAN (SERVICEMASTER TBS) 105
TABLE 28 SERVICEMASTER CLEAN.: BUSINESS OVERVIEW 105
9.9 CORVUS JANITORIAL SYSTEMS 107
TABLE 29 CORVUS JANITORIAL SYSTEMS: BUSINESS OVERVIEW 107
9.10 BRAVO! BUILDING SERVICES 109
TABLE 30 BRAVO! BUILDING SERVICES: BUSINESS OVERVIEW 109
9.11 POWERLINK ENVIRONMENTAL SERVICES, LLC 111
TABLE 31 POWERLINK ENVIRONMENTAL SERVICES, LLC: BUSINESS OVERVIEW 111
9.12 JANI-KING INTERNATIONAL, INC. 112
TABLE 32 JANI- KING INTERNATIONAL, INC: BUSINESS OVERVIEW 112
9.13 AVI FOOD SYSTEMS(US) 114
TABLE 33 AVI FOOD SYTEMS, INC.: BUSINESS OVERVIEW 114
9.14 SERVICON 115
TABLE 34 SERVICON: BUSINESS OVERVIEW 115
9.15 XANITOS, INC. 117
TABLE 35 XANITOS, INC.: BUSINESS OVERVIEW 117
9.16 STATHAKIS 119
TABLE 36 STATHAKIS: BUSINESS OVERVIEW 119
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
10 APPENDIX 120
10.1 INSIGHTS FROM INDUSTRY EXPERTS 120
10.2 DISCUSSION GUIDE 121
10.3 KNOWLEDGESTORE: MARKETSANDMARKETS SUBSCRIPTION PORTAL 124
10.4 AVAILABLE CUSTOMIZATIONS 126
10.5 RELATED REPORTS 126
10.6 AUTHOR DETAILS 127